{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:59:26Z","timestamp":1772265566939,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:00:00Z","timestamp":1404259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00417-014-2691-6","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T07:38:39Z","timestamp":1404286719000},"page":"1309-1313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy"],"prefix":"10.1007","volume":"252","author":[{"given":"Morteza","family":"Entezari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuchehr","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"key":"2691_CR1","first-page":"487","volume":"38","author":"SKF Goldberg RA","year":"1994","unstructured":"Goldberg RA SKF, Goldberg RA (1994) Traumatic optic neuropathy 38:487\u2013518","journal-title":"Traumatic optic neuropathy"},{"key":"2691_CR2","unstructured":"al-Qurainy Ia Fau - Stassen LF, Stassen Lf Fau - Dutton GN, Dutton Gn Fau - Moos KF, Moos Kf Fau - el-Attar A, el-Attar A (1991) The characteristics of midfacial fractures and the association with ocular injury: a prospective study Br J Oral Maxillofac Surg. 29:291\u2013301"},{"key":"2691_CR3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00417-006-0441-0","volume":"245","author":"M Entezari","year":"2007","unstructured":"Entezari M, Rajavi Z, Sedighi N, Daftarian N, Sanagoo M (2007) High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245:1267\u20131271","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2691_CR4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00002341-200205000-00016","volume":"18","author":"KD Steinsapir","year":"2002","unstructured":"Steinsapir KD, Seiff SR, Goldberg RA (2002) Traumatic optic neuropathy: where do we stand? Ophthal Plast Reconstr Surg 18:232\u2013234","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2691_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/978-0-387-68979-1_5","volume-title":"Optic nerve disorders. Diagnosis and management","author":"JW Chan","year":"2007","unstructured":"Chan JW (2007) Optic nerve disorders. Diagnosis and management. Springer, Berlin Heidelberg, pp 130\u2013144"},{"key":"2691_CR6","first-page":"157","volume":"17","author":"KD Steinsapir","year":"2000","unstructured":"Steinsapir KD, Goldberg RA, Sinha S, Hovda DA (2000) Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci 17:157\u2013163","journal-title":"Restor Neurol Neurosci"},{"key":"2691_CR7","unstructured":"Miller NR, Newman NJ, Biousse V (2008) Walsh and Hoyt\u2019s clinical neuro-ophthalmology: the essentials. Lippincott and william &Wilkins. Lippincott and William &Wilkins, Philadelphia"},{"key":"2691_CR8","first-page":"236","volume":"32","author":"MJ Shepard","year":"1994","unstructured":"Shepard MJ, Bracken MB (1994) The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study Paraplegia 32:236\u2013245","journal-title":"National Acute Spinal Cord Injury Study Paraplegia"},{"key":"2691_CR9","first-page":"76","volume":"6","author":"KG Falavarjani","year":"2011","unstructured":"Falavarjani KG, Modarres M (2011) Erythropoietin; a novel neuroprotective agent for ocular disorders. Journal of ophthalmic & vision research 6:76\u201377","journal-title":"Journal of ophthalmic & vision research"},{"key":"2691_CR10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","volume":"95","author":"M Modarres","year":"2011","unstructured":"Modarres M, Falavarjani KG, Nazari H, Sanjari MS, Aghamohammadi F, Homaii M, Samiy N (2011) Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 95:992\u2013995","journal-title":"Br J Ophthalmol"},{"key":"2691_CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00417-010-1534-3","volume":"249","author":"MB Kashkouli","year":"2011","unstructured":"Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, Heirati A (2011) Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Graefes Arch Clin Exp Ophthalmol 249:731\u2013736","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2691_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0039-6257(81)90124-7","volume":"26","author":"HS Thompson","year":"1981","unstructured":"Thompson HS, Corbett JJ, Cox TA (1981) How to measure the relative afferent pupillary defect. Surv Ophthalmol 26:39\u201342","journal-title":"Surv Ophthalmol"},{"key":"2691_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/brain\/awh645","volume":"129","author":"T Sairanen","year":"2006","unstructured":"Sairanen T, Karjalainen-Lindsberg ML, Paetau A, Ijas P, Lindsberg PJ (2006) Apoptosis dominant in the periinfarct area of human ischaemic stroke\u2013a possible target of antiapoptotic treatments. Brain: a journal of neurology 129:189\u2013199","journal-title":"Brain: a journal of neurology"},{"key":"2691_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","volume":"228","author":"JW Fisher","year":"2003","unstructured":"Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Experimental biology and medicine 228:1\u201314, Maywood, NJ","journal-title":"Experimental biology and medicine"},{"key":"2691_CR15","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.152321399","volume":"99","author":"AK Junk","year":"2002","unstructured":"Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99:10659\u201310664","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2691_CR16","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, Sir\u00e9n AL, Paulus W, Nave KA, Gold R, Bartels C (2007) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130:2577\u201388","journal-title":"Brain"},{"key":"2691_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","volume":"8","author":"H Ehrenreich","year":"2002","unstructured":"Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren A, Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495\u2013505, Cambridge, Mass","journal-title":"Mol Med"},{"key":"2691_CR18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.neuropharm.2012.06.037","volume":"63","author":"H Tan","year":"2012","unstructured":"Tan H, Zhong Y, Shen X, Cheng Y, Jiao Q, Deng L (2012) Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA\/ROCK signaling pathway. Neuropharmacology 63:1182\u20131190","journal-title":"Neuropharmacology"},{"key":"2691_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejps.2011.05.011","volume":"43","author":"X Rong","year":"2011","unstructured":"Rong X, Mo X, Ren T, Yang S, Yuan W, Dong J, Wang Y, Wang X (2011) Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 43:334\u2013342","journal-title":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"key":"2691_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2012.01.006","volume":"96","author":"TA Sullivan","year":"2012","unstructured":"Sullivan TA, Geisert EE, Templeton JP, Rex TS (2012) Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin. Exp Eye Res 96:36\u201341","journal-title":"Exp Eye Res"},{"key":"2691_CR21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","volume":"6","author":"AL Siren","year":"2009","unstructured":"Siren AL, Fasshauer T, Bartels C, Ehrenreich H (2009) Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 6:108\u2013127","journal-title":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"2691_CR22","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.1073\/pnas.142287899","volume":"99","author":"A Gorio","year":"2002","unstructured":"Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99:9450\u20139455","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2691_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2007.01.017","volume":"205","author":"CE King","year":"2007","unstructured":"King CE, Rodger J, Bartlett C, Esmaili T, Dunlop SA, Beazley LD (2007) Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 205:48\u201355","journal-title":"Exp Neurol"},{"key":"2691_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1756285608098422","volume":"1","author":"C Bartels","year":"2008","unstructured":"Bartels C, Spate K, Krampe H, Ehrenreich H (2008) Recombinant human erythropoietin: novel strategies for neuroprotective\/neuro-regenerative treatment of multiple sclerosis. Ther Adv Neurol Disord 1:193\u2013206","journal-title":"Ther Adv Neurol Disord"},{"key":"2691_CR25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1167\/iovs.03-1039","volume":"45","author":"JH Weishaupt","year":"2004","unstructured":"Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45:1514\u20131522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2691_CR26","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1523\/JNEUROSCI.23-10-04023.2003","volume":"23","author":"T Kurimoto","year":"2003","unstructured":"Kurimoto T, Miyoshi T, Suzuki A, Yakura T, Watanabe M, Mimura O, Fukuda Y (2003) Apoptotic death of beta cells after optic nerve transection in adult cats. The Journal of neuroscience : the official journal of the Society for Neuroscience 23:4023\u20134028","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"2691_CR27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cardiores.2006.07.001","volume":"71","author":"Q Feng","year":"2006","unstructured":"Feng Q (2006) Beyond erythropoiesis: the anti-inflammatory effects of erythropoietin. Cardiovasc Res 71:615\u2013617","journal-title":"Cardiovasc Res"},{"key":"2691_CR28","doi-asserted-by":"crossref","unstructured":"Katavetin P, Tungsanga K, Eiam-Ong S, Nangaku M (2007) Antioxidative effects of erythropoietin. Kidney international Supplement: S10-15","DOI":"10.1038\/sj.ki.5002482"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2691-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2691-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T09:37:19Z","timestamp":1565602639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2691-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,2]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2691-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,2]]}}}